EUVIMEDEUVIMED entdecken
Crossref

The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016–2022

Silvia S Chiang iD, Jonathon R Campbell iD, Daniele Maria Pelissari iD, Márcia C Bellotti de Oliveira, Anna Cristina C Carvalho iD, Sylvia M LaCourse iD, Clemax C Sant'Anna iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Silvia S Chiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatics, Division of Pediatric Infectious Diseases, Alpert Medical School of Brown University, Providence, RI, USA. Hauptthemen laut MEDLINE: Antitubercular Agents, Pregnancy Complications, Infectious, Tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

More than 200 000 pregnant people fall ill with tuberculosis (TB) annually. Little is known about the impact of pregnancy on TB outcomes.

Methods

This study used surveillance data from Brazil's Ministry of Health. We included women aged 11–49 years newly diagnosed with drug-susceptible TB disease between 2016 and 2022, treated with a first-line anti-TB regimen, and with a known treatment outcome. Using multivariable regression, we estimated the age-stratified effect of pregnancy on (1) loss to follow-up and (2) death during TB treatment.

Results

Of 96 868 women with TB, 1870 (1.9%) were pregnant, 79 361 (81.9%) were not pregnant, and 15 637 (16.1%) had unknown pregnancy status. Among pregnant women, 1432 (76.6%) experienced treatment success, 358 (19.1%), lost to follow-up, and 80 (4.3%) died. Among nonpregnant women, 79 262 (83.4%) experienced treatment success, 11 582 (12.2%) were lost to follow-up, and 4154 (4.4%) died. In adolescents, pregnancy conferred higher odds of loss to follow-up (adjusted odds ratio [aOR], 1.78; 95% confidence interval [CI]: 1.29–2.44) and death (aOR, 2.35; 95% CI: 1.27–4.37). Compared to nonpregnant women of the same age, pregnant women aged 20–29 and 30–39 years experienced more loss to follow-up (respectively: aOR, 1.39; 95% CI: 1.17–1.66 and aOR 1.79; 95% CI, 1.42–2.25), while those aged 40–49 years were more likely to die (aOR, 1.66; 95% CI: 1.04–2.66).

Conclusions

Our analysis revealed a significant association between pregnancy and poor TB treatment outcomes, highlighting the need for care providers to offer enhanced support and monitoring for pregnant women undergoing TB treatment. Further research is needed to identify the underlying reasons for these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsPregnancy Complications, InfectiousTuberculosisHumansFemalePregnancyAdultBrazilAdolescentYoung AdultMiddle AgedChildTreatment OutcomeLost to Follow-Up

Stichwörter der Autor:innen

adolescentloss to follow-upmaternalmortalityprenatal

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Pediatics, Division of Pediatric Infectious Diseases, Alpert Medical School of Brown University, Providence, RI, USA.
  • Center for International Health Research, Rhode Island Hospital, Providence, RI, USA.
  • Department of Medicine and Department of Global and Public Health, McGill University, Montreal, QC, Canada.
  • McGill International TB Centre, Montreal, QC, Canada.
  • Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Health and Environment Surveillance Secretariat, Ministry of Health, Brasilia, Brazil.

ORCID-Profile: Silvia S Chiang, Jonathon R Campbell, Daniele Maria Pelissari, Anna Cristina C Carvalho, Sylvia M LaCourse, Clemax C Sant'Anna

Zitieren

APA

Chiang, S. S., Campbell, J. R., Pelissari, D. M., de Oliveira, M. C. B., Carvalho, A. C. C., LaCourse, S. M., & Sant'Anna, C. C. (2026). The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016–2022. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf233

Vancouver

Chiang SS, Campbell JR, Pelissari DM, de Oliveira MCB, Carvalho ACC, LaCourse SM, et al. The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016–2022. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf233

BibTeX
@article{Chiang2026,
  author = {Chiang, Silvia S and Campbell, Jonathon R and Pelissari, Daniele Maria and de Oliveira, Márcia C Bellotti and Carvalho, Anna Cristina C and LaCourse, Sylvia M and Sant'Anna, Clemax C},
  title = {The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016–2022},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf233}
}
Kostenlos starten →